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Immunoglobulin G4 (IgG4)-associated disease is a recently recognized disease entity that is characterized by elevated
serum IgG4 concentrations, abundant IgG4 lymphoplasmacytic infiltration, and dramatic steroid responses. IgG4-associated
cholangitis is one manifestation of IgG4-associated disease. However, it is clinically challenging to make a preoperative
differentiation between this rare disease and cholangiocarcinoma, especially for those with serum concentrations of IgG4 in
the normal range. This article reports on a 57-year-old man with jaundice and upper abdominal discomfort. Imaging
examination showed biliary stricture that closely resembled cholangiocarcinoma, and the patient’s serum IgG4
concentration was normal. The patient underwent a laparoscopic choledochectomy with Roux-en-Y hepaticojejunostomy
using an intracorporeal hand-sewn technique. He recovered quickly without any complications. We also present our
experience in laparoscopic intracorporeal hand-sewn hepaticojejunostomy.
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IgG4-associated systemic disease (ISD) is a systemic disorder
involving multiple organs associated with increased IgG4
serum levels or IgG4 positive plasma cell infiltrates. IgG4-
associated cholangitis (IAC) is one manifestation of ISD.
However, the clinical, biochemical, and imaging features of
IAC mimic cholangiocarcinoma, making preoperative accur-
ate diagnosis difficult [1]; therefore, surgery remains a thera-
peutic choice, so as to avoid omitting malignancy.
Since the development of minimally invasive surgical ap-
proaches [2], laparoscopic surgery for biliary tract diseases
has evolved rapidly over the past decade, and laparoscopic
Roux-en-Y cholangiojejunostomy and hepaticojejunostomy
are accepted for the treatment of such diseases. On the
basis of our extensive laparoscopic experience gained from
laparoscopic gastrectomy and pancreatectomy, as well as
other laparoscopic operations [3-6], we were encouraged
to develop an intracorporeal hand-sewn technique for* Correspondence: mouyiping2002@163.com
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unless otherwise stated.reconstruction. Herein, we report a case of IAC preopera-
tively diagnosed as cholangiocarcinoma and successfully
treated by laparoscopic hepaticojejunostomy with our intra-
corporeal hand-sewn technique.Case presentation
A 57-year-old man was admitted to our department; he
had jaundice and had been experiencing upper abdominal
discomfort for the previous month. Laboratory data were
as follows: alkaline phosphatase, 303 U/l; alanine amino-
transferase, 266 IU/l; aspartate aminotransferase, 70 IU/l;
γ-glutamyltransferase, 555 U/l; total bilirubin, 126 μmol/dl;
direct bilirubin, 102.0 μmol/l. The patient’s serum levels of
carcinoembryonic antigen and α-fetoprotein were within
normal limits; however, serum carbohydrate antigen 19-9
concentration was 306 IU/ml. Other test results, including
IgG4 serum levels, were all within normal ranges.
Enhanced abdominal computed tomography revealed
a mass involving the common hepatic duct (Figure 1A).
Magnetic resonance cholangiopancreatography revealed
a stricture at the upper middle segment of the common
hepatic duct, together with proximal bile duct dilatation. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Preoperative imaging examination. (A) Computed tomography showed biliary stricture (white arrow). (B) Magnetic resonance
cholangiopancreatography revealed biliary stricture (black arrow) and dilatation at the top of the stricture.
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angiocarcinoma, resulting in biliary stenosis and jaun-
dice. Therefore, laparoscopic choledochectomy with
Roux-Y hepaticojejunostomy was selected.
The patients’ position and the placement of trocars were
similar to our previous studies [7] (Figure 2). The hepato-
duodenal ligament was divided by ultrasonic coagulating
shears (Figure 3A). Then the common hepatic artery, com-
mon bile duct and portal vein were visualized (Figure 3B).
Calot’s triangle was identified and the cystic artery wasFigure 2 Trocar placement.clipped and divided while the cystic duct was clipped and
left in situ (Figure 3C). The biliary tract, including the com-
mon bile duct, common hepatic duct and left and right
hepatic ducts was divided further from the portal vein. The
portal vein and common hepatic artery were then sepa-
rated from the surrounding tissue upward to the hilar
plate. Lymphadenectomy around the pancreatic head was
performed. The mass was found at the middle of the com-
mon bile duct. The dilated left and right hepatic ducts
were transected 1.0 cm above the mass (Figure 3D), and
Figure 3 Resection of mass on biliary duct. (A) Division of hepatoduodenal ligament. (B) Visualization of properhepatic artery, common bile
duct, and portal vein. (C) The cystic artery was clipped and divided while the cystic duct was clipped and left in situ. (D) Transection of left and
right hepatic ducts 1.0 cm above the mass. (E) Traversal of common bile duct about 0.5 cm below the mass. CBD, common bile duct; LHA, left
hepatic artery; LHD, left hepatic duct; PHA, proper hepatic artery; PV, portal vein; RHD, right hepatic duct; RPV, right portal vein.
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the mass (Figure 3E). The resected tissue and the gallblad-
der were taken out in an endoscopic retrieval bag through
the umbilical incision.
The incision was sutured, and the pneumoperitoneum
was reestablished. After exploring the upper jejunum about
25 cm distally from the ligament of Treitz, an incision was
made in the mesentery of this loop, and a transection of the
jejunum was performed with an endoscopic linear stapler
(Figure 4A). The left and right hepatic ducts and the distal
limb were then approximated using a draft line (Figure 4B),
and a 5 mm wide incision was made at the antimesenteric
side of the jejunum (Figure 4C) for end-to-side hepaticoje-
junostomy. At the 3 o’clock and 9 o’clock positions of the
anastomotic stoma, the sutures were held as long stay
sutures to lift the corners (Figure 4D). The posterior wall of
the hepaticojejunostomy was sutured using interrupted su-
tures (Figure 4E,F) and the anterior wall was sutured using
a continuous suture (Figure 4G). The seromuscular layerwas strengthened with interrupted sutures to reduce
tension (Figure 4H). Then a side-to-side jejunojejunostomy
was performed through the enlarged umbilical incision. Fi-
nally, a peritoneal cavity drainage tube was placed posterior
to the bilioenteric anastomosis.
The operative time was 210 min and blood loss was 60
ml. The intraoperative frozen pathological diagnosis was
probably IAC, rather than cholangiocarcinoma, and the
margins were negative. The gross finding was a 20 × 15
mm mass located in the middle part of the common bile
duct, in communication with a dilated proximal bile duct
(Figure 5). Microscopically, lymphoplasmacytic infiltrate
was identified, with a moderate CD138 positive plasma
cell infiltration (Figure 6A) and abundant IgG4 positive
cells (Figure 6B).
The postoperative course was uneventful. The patient
started to take semi-fluid on the day after surgery. As
there were no complications such as hemorrhage or bile
leak, the drainage tube was removed on postoperative day
Figure 4 Intracorporeal side-to-side jejunojejunostomy. (A) Transection of the jejunum with an endoscopic linear stapler. (B) Approximation
of left and right hepatic ducts and distal limb using a draft line. (C) A 5 mm wide incision at the antimesenteric side of the jejunum. (D) Long
stay sutures to lift the corners at the 3 o’clock and 9 o’clock positions of the anastomotic stoma. (E,F) Suture of the posterior wall using
interrupted sutures (G) Suture of the anterior wall using a continuous suture. (H) Strengthening of the seromuscular layer with interrupted
sutures to reduce tension. LHD, left hepatic duct; RHD, right hepatic duct.
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The patient was followed up for 10 months. He did not take
any drugs after surgery, his serum concentration of IgG4
was within the normal range, and other laboratory tests gave
normal results.
Discussion
Since Hamano et al. [8] first proposed a new term of sys-
temic IgG4-associated autoimmune disease in 2001, ISDhas become a novel clinicopathological disease entity. This
is a systemic disease that can involve multiple organs,
such as the pancreas, biliary duct, central nervous system,
lacrimal or salivary glands, lungs, liver, kidneys, prostate
gland, skin, arteries, lymph nodes. The key histopathologic
findings are abundant IgG4 lymphoplasmacytic infiltrate,
obliterative phlebitis, and an eosinophil infiltrate [1].
Autoimmune pancreatitis and IAC are the most common
manifestations of ISD; IAC is the biliary manifestation of
Figure 5 Surgical specimen, showing a mass in the common
bile duct.
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Although the diagnosis of IAC is often established based on
a combination of clinical, serologic, radiological, and histo-
logic findings, strict criteria for IAC are lacking [9]. Several
diagnostic criteria have been proposed, following the initial
Japanese consensus criteria for the diagnosis of auto-
immune pancreatitis [10]. The HISORt (histology, imaging,
serology, other organ involvement, and response to cortico-
steroid) criteria [11] for autoimmune pancreatitis and the
variant criteria for IAC [12], as well as the Asian consensus
criteria [13] have been the most commonly applied criteria
for diagnosing autoimmune pancreatitis and IAC. Limited
epidemiologic data exist on the rarity of IAC. Studies have
reported that IAC is found mostly in men older than 50
years [9]. Notwithstanding the fact that the clinical presen-
tation of patients with IAC is highly variable, obstructive
jaundice is most common, present in up to 75% of patients
[9]. Patients may present with other symptoms, such asFigure 6 Immunostained bile duct specimens. (A) Moderate CD138-pos
cells, ×100.abdominal pain, weight loss, pruritus, and biochemical
signs of pancreatitis and cholestasis [12].
The low clinical specificity makes it difficult to distin-
guish IAC from cholangiocarcinoma. Although a serum
IgG4 increase is characteristic of IAC, it may not be
diagnostic of the disease. The sensitivity and accuracy of
serum IgG4 for ISD were reported as 50% and 60%,
respectively [14]. According to a recent study from the
Mayo Clinic, which investigated the ability of IgG4 to
distinguish IAC from cholangiocarcinoma reliably,
serum IgG4 levels more than twice the upper limits of
normal provided a specificity of 97% and a sensitivity of
50% in distinguishing IAC from cholangiocarcinoma
[15]. Nevertheless, an IgG4 increase does occur in the
absence of ISD, and hence increased serum IgG4 levels
alone should not be used to diagnose IAC. Serum CA
19-9 levels can also be of use because concentrations
greater than 100 IU/ml are less likely in IAC than in
cholangiocarcinoma (18% versus 60% to 80%) [16,17]. In
addition, biliary strictures in IAC also do not have any
highly specific diagnostic features, unlike autoimmune
pancreatitis, in which typical pancreatic imaging
features, such as diffuse sausage-shaped pancreatic en-
largement and diffuse irregular narrowing of the pancre-
atic duct, have been described. Imaging often shows
proximal bile duct or intrahepatic strictures with dilata-
tion of the upstream biliary system, along with sclerosing
changes, which are quite similar to cholangiocarcinoma.
This indicates that, while imaging modalities are useful
in determining the level of bile duct obstruction, they
are limited when it comes to establishing a definitive
diagnosis, distinguishing IAC from malignant biliary
strictures reliably [18,19].
An unexplained biliary stricture, not caused by trauma
or choledocholithiasis, is often presumed to be caused
by malignancy. In our case, with normal serum concen-
trations of IgG4 (1.86 g/l) and apparently elevated levelsitive plasma cell infiltration, ×100. (B) Abundant IgG4-positive plasma
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and no other organ involvement were assumed to indicate
ISD; it is extremely difficult to distinguish IAC from chol-
angiocarcinoma preoperatively. Although endoscopic retro-
grade cholangiopancreatography is the most commonly
performed procedure for cholangiocarcinoma and can pro-
vide a tissue diagnosis through brush cytology of the bile
duct, the sensitivity of biliary brush cytology to diagnose
cholangiocarcinoma may be as low as 30% [20]. Although
endoscopic ultrasonography can complement the role of
endoscopic retrograde cholangiopancreatography and pro-
vide a tissue diagnosis through fine needle aspiration and
staging through ultrasound imaging, it can also lead to
tumor seeding [20]. Hence, choledochectomy with Roux-
en-Y hepaticojejunostomy was performed.
The laparoscopic technique is indispensable in biliary
surgery. Compared with traditional open surgery, most
studies have reported that laparoscopic techniques can
achieve better cosmesis, shorter hospital stay, and faster
postoperative recovery [21-24]. By choosing the laparo-
scopic approach, not only are the incision complications
minimized, but also the quality of visualization is sig-
nificantly enhanced, leading to greater precision in the
control of reconstructions. However, it is important to
have an experienced hand with wonderful skills. As with
open surgery, laparoscopic ductoplasty appears to be
technically possible in experienced hands. A proper
wide hepaticojejunostomy must be performed for suffi-
cient bile drainage. After surgery, the anastomotic
stoma would become smaller because of inflammation
and denuded epithelial mucosa of the bile duct. The
posterior wall anastomosis is the most challenging step.
Based on our experience, keeping the long corner stay
sutures at the 3 o’clock and 9 o’clock positions of the
anastomotic stoma was able to maintain tension to pro-
vide a clear view of posterior wall and allow more pre-
cise anastomosis. Maintaining the integrity of this
anastomosis is important, and lessening the tension of
the anastomosis is also a key point in preventing the
occurrence of bile leakage. The intestinal mesentery
should be isolated from the mesenteric root as much as
possible, to ensure appropriate mobility of the biliary
limb. In addition, the greater omentum should be sepa-
rated if necessary. Moreover, interrupted sutures of ser-
omuscular layer are also helpful, to reduce tension.Conclusions
Our case suggests that totally laparoscopic Roux-en-Y
hepaticojejunostomy using an intracorporeal hand-sewn
technique is a feasible procedure. Adequate preoperative
evaluation, appropriate intraoperative hand-sewn tech-
niques, and highly skilled laparoscopic techniques are the
key factors of success in laparoscopic hepaticojejunostomy.Consent
Written informed consent was obtained from the patient
for the publication of this case report and any accom-
panying images.
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